Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias*

@article{Gregory2010IdentificationOO,
  title={Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias*},
  author={Karen J. Gregory and Nathan E. Hall and Andrew B. Tobin and Patrick M. Sexton and Arthur Christopoulos},
  journal={The Journal of Biological Chemistry},
  year={2010},
  volume={285},
  pages={7459 - 7474}
}
Muscarinic acetylcholine receptors contain at least one allosteric site that is topographically distinct from the acetylcholine, orthosteric binding site. Although studies have investigated the basis of allosteric modulation at these receptors, less is known about putative allosteric ligands that activate the receptor in their own right. We generated M2 muscarinic acetylcholine receptor mutations in either the orthosteric site in transmembrane helices 3 and 6 (TM3 and -6) or part of an… Expand
Structural Determinants of Allosteric Agonism and Modulation at the M4 Muscarinic Acetylcholine Receptor
TLDR
These results provide new insights into the existence of multiple activation switches in G protein-coupled receptors (GPCRs), some of which can be selectively exploited by allosteric agonists, whereas others represent global activation mechanisms for all classes of ligand. Expand
Orthosteric and Allosteric Modes of Interaction of Novel Selective Agonists of the M1 Muscarinic Acetylcholine Receptor
TLDR
A novel mutation is identified, F77I (transmembrane helix 2), which selectively reduced the efficacy of the novel agonists in mediating intracellular Ca2+ elevation and phosphorylation of extracellular signal regulated kinase 1/2. Expand
The Role of Transmembrane Domain 3 in the Actions of Orthosteric, Allosteric, and Atypical Agonists of the M4 Muscarinic Acetylcholine Receptor
Despite the discovery of a diverse range of novel agonists and allosteric modulators of the M4 muscarinic acetylcholine (ACh) receptor (mAChR), little is known about how such ligands activate theExpand
Structure-function studies of M4 muscarinic acetylcholine receptor allosteric modulation
The M4 muscarinic acetylcholine receptor (mAChR) is implicated in many central nervous system disorders, however, due to a highly conserved acetylcholine (ACh) binding orthosteric site, there is aExpand
Reverse Engineering of the Selective Agonist TBPB Unveils Both Orthosteric and Allosteric Modes of Action at the M1 Muscarinic Acetylcholine Receptor
TLDR
It is proposed that TBPB is a bitopic ligand, interacting with both the orthosteric site and an allostericSite, at the M1 mAChR, and should be taken into consideration in the profiling and classification of new novel selective agonists for this receptor family. Expand
Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor*
TLDR
Findings provide valuable structural and mechanistic insights into bitopic ligand actions and receptor activation and support a role for ECL2 in dictating the active states that can be adopted by a G protein-coupled receptor. Expand
Characterization of the Novel Positive Allosteric Modulator, LY2119620, at the Muscarinic M2 and M4 Receptors
TLDR
It is demonstrated that an allosteric ligand can positively modulate the binding and functional efficacy of this high efficacy ligand, LY2119620, and this work expands the characterization of the orthosteric agonist, iperoxo, at the M4 receptor. Expand
Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors
TLDR
It is shown that high concentrations of either QNB or NMS slow down dissociation of their radiolabeled species from all five subtypes of muscarinic acetylcholine receptors, suggesting allosteric binding. Expand
Exploration of the Orthosteric/Allosteric Interface in Human M1 Muscarinic Receptors by Bitopic Fluorescent Ligands
TLDR
Evidence is provided that fluorescent pirenzepine derivatives, with the M1 antagonist fused to the boron-dipyrromethene [Bodipy (558/568)] fluorophore via spacers of varying lengths, exhibit orthosteric/allosteric binding properties at muscarinic M1 receptors, demonstrating the importance of a “multifacet” experimental approach to unravel and validate bitopic ligand binding mechanisms. Expand
Probe Dependence in the Allosteric Modulation of a G Protein-Coupled Receptor: Implications for Detection and Validation of Allosteric Ligand Effects
TLDR
It is shown that LY2033298 can also bind to the M2 mAChR and mediate robust positive or negative allosteric effects, depending on the orthosteric ligand used as a probe of receptor activity, and this finding of striking “probe dependence” indicates that the previously described selectivity of the modulator does not arise as a consequence of selective affinity for a poorly conservedallosteric site. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 80 REFERENCES
Structure-Function Studies of Allosteric Agonism at M2 Muscarinic Acetylcholine Receptors
TLDR
A differential role of criticalAllosteric site residues on the binding and function of allosteric agonists versus allosterics modulators of M2 mAChRs is revealed. Expand
Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
TLDR
Two amino acids account entirely for the (approximately 100-fold) M2/M5 selectivity of the alkane-bisammonium and the caracurine V type allosteric ligands at NMS-free M2 receptors. Expand
Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.
TLDR
Analysis of numerous point mutations in this region of the M(5) receptor found that a mutation of V --> N resulted in an increased affinity toward gallamine, suggesting that the asparagine residue at M(2)(419) is responsible for gallamine's M( 2)/M(5] selectivity. Expand
Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis.
In an attempt to locate the allosteric site on muscarinic receptors to which gallamine binds, 21 residues in the putative external loops and loop/transmembrane helix interfaces have been mutated toExpand
Structural Requirements of Transmembrane Domain 3 for Activation by the M1 Muscarinic Receptor Agonists AC-42, AC-260584, Clozapine, and N-Desmethylclozapine: Evidence for Three Distinct Modes of Receptor Activation
TLDR
The results show that M1 receptors can be activated in at least three distinct ways and that there is no requirement for potent muscarinic agonists to mimic acetylcholine interactions with TM3. Expand
Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
TLDR
These studies demonstrate that a stereochemical difference can be sufficient to translate into divergent epitope sensitivities and are the first time that the subtype selectivity of muscarinic allosteric agents has been completely accounted for by distinct receptor epitopes. Expand
Mutagenic Mapping Suggests a Novel Binding Mode for Selective Agonists of M1 Muscarinic Acetylcholine Receptors
TLDR
The hypothesis that the sidechain of Trp101 undergoes conformational isomerization, opening a novel binding site for the aromatic side chain of the AC-42 analogs, may allow the positively charged piperidine nitrogen of the ligands to access the neighboring Asp105 carboxylate to activate signaling following a vector within the binding site that is distinct from that of acetylcholine. Expand
A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity
TLDR
Results are consistent with McN-A-343 being a bitopic orthosteric/allosteric ligand with the allosteric moiety engendering partial agonism and functional selectivity, and suggest a novel and largely unappreciated mechanism of “directed efficacy” wherebyfunctional selectivity may be engendered in a GPCR by utilizing an allosterics ligand to direct the signaling of an orthosterIC ligand encoded within the same molecule. Expand
Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
TLDR
Characterization of a novel highly selective agonist for the M1 receptor with no agonist activity at any of the other mAChR subtypes, termed TBPB, and data suggest that selective activation of M1 may provide a novel approach for the treatment of symptoms associated with schizophrenia and Alzheimer's disease. Expand
Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity
TLDR
M2422Trp and the spatially adjacent M2177Tyr, as well as M2423Thr, form a cluster of amino acids within the allosteric binding cleft that is pivotal for both M2/M5 subtype selectivity and baseline affinity ofallosteric agents. Expand
...
1
2
3
4
5
...